NAD+ and CD38: How Researchers Study NAD+ Consumption and Cellular Signalling
Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme involved in cellular energy metabolism, redox reactions and numerous biochemical signalling pathways.
Although NAD+ is frequently discussed in relation to mitochondrial function and cellular energy production, researchers are also interested in the enzymes responsible for consuming and regulating NAD+.
One of these enzymes is CD38, a multifunctional protein involved in NAD+ metabolism, immune-cell activity and calcium signalling.
Understanding the relationship between NAD+ and CD38 provides researchers with valuable insight into how cells regulate NAD+ availability and how this regulation changes under different experimental conditions.
What Is CD38?
CD38, also known as cluster of differentiation 38, is a multifunctional protein expressed on the surface of various cell types, particularly immune cells.
It functions both as a cell-surface protein involved in cellular interactions and as an enzyme capable of metabolising NAD+.
CD38 is commonly described as an NAD+ glycohydrolase, or NADase, because one of its primary enzymatic activities involves breaking down NAD+.
This makes CD38 an important component of cellular NAD+ regulation.
Researchers investigate CD38 to better understand:
-
NAD+ consumption and turnover
-
Immune-cell signalling
-
Calcium mobilisation
-
Cellular responses to inflammation
-
Changes in NAD+ metabolism associated with ageing
-
Interactions between NAD+-consuming enzymes
CD38 is particularly interesting because its activity can influence NAD+ availability without directly participating in the mitochondrial electron transport chain.
How Does CD38 Consume NAD+?
CD38 primarily metabolises NAD+ through a reaction that produces nicotinamide and ADP-ribose.
The simplified reaction is:
NAD+ → Nicotinamide + ADP-ribose
CD38 can also catalyse reactions that produce cyclic ADP-ribose (cADPR), although this represents a smaller proportion of its NAD+-metabolising activity.
ADP-ribose and cyclic ADP-ribose are involved in cellular signalling processes, including pathways associated with calcium regulation.
Consequently, CD38 has two closely connected areas of research interest:
-
Its role in consuming NAD+ and influencing NAD+ availability.
-
Its role in generating signalling molecules involved in cellular communication.
These functions make CD38 relevant to research investigating how metabolic processes interact with intracellular signalling pathways.
For a broader explanation of NAD+-dependent biochemical reactions, see our NAD+ Mechanism of Action research guide.
NAD+ and CD38 in Cellular Metabolism
Cells continuously synthesise, recycle and consume NAD+.
The availability of NAD+ depends on the balance between these processes.
NAD+ biosynthesis pathways replenish cellular NAD+ pools, while NAD+-consuming enzymes use NAD+ as a substrate for specific biochemical reactions.
CD38 contributes to this balance through its NADase activity.
When researchers investigate CD38, they may examine how changes in enzyme expression or activity influence NAD+ concentrations within particular tissues or cellular compartments.
Importantly, NAD+ metabolism is compartmentalised. NAD+ concentrations and turnover can differ between the cytoplasm, nucleus, mitochondria and extracellular environment.
CD38 is often found at the cell surface, where its catalytic activity can influence extracellular NAD+ and related metabolites. Intracellular forms of CD38 have also been described.
This distinction matters because changes in total tissue NAD+ do not necessarily reflect identical changes in every cellular compartment.
For further information on the relationship between NAD+ and mitochondrial energy metabolism, explore our NAD+ and Mitochondrial Function research guide.
Why Is CD38 Studied in Ageing Research?
One of the most widely investigated aspects of CD38 biology is its relationship with age-associated changes in NAD+ metabolism.
Experimental studies have reported increased CD38 expression or activity in certain tissues during ageing.
Researchers have also observed that changes in immune-cell populations and inflammatory signalling can influence CD38 expression.
In some animal models, increased CD38 activity has been associated with reduced NAD+ availability.
These observations have generated interest in whether CD38 contributes to changes in NAD+ metabolism during ageing.
However, the relationship is complex.
CD38 expression varies between tissues and cell types, and findings from experimental models cannot automatically be generalised to humans.
Age-associated changes in NAD+ metabolism also involve multiple pathways beyond CD38, including NAD+ biosynthesis, mitochondrial metabolism and other NAD+-consuming enzymes.
Therefore, CD38 is best understood as one component of a wider NAD+ regulatory network.
CD38 and Immune-Cell Research
CD38 is expressed by several immune-cell populations and is frequently studied in immunology.
Researchers investigate its involvement in immune-cell activation, differentiation and cellular communication.
CD38 expression may also change in response to inflammatory conditions.
This is relevant to NAD+ research because immune-cell activity can influence tissue metabolism.
For example, experimental research has investigated how inflammatory signalling and the accumulation of particular immune-cell populations affect CD38 expression and NAD+ availability.
Such studies help researchers explore connections between immune-system activity and metabolic regulation.
However, CD38 expression alone does not establish a specific inflammatory state or predict a particular biological outcome.
Its significance depends on the cell type, experimental model and wider signalling environment.
CD38 and Calcium Signalling
Another important function of CD38 involves the generation and metabolism of molecules associated with calcium signalling.
Calcium ions act as intracellular messengers involved in numerous cellular processes.
These include enzyme regulation, secretion, cellular communication and responses to external signals.
CD38 participates in pathways involving ADP-ribose and cyclic ADP-ribose, which can influence calcium mobilisation.
Researchers study these reactions to understand how NAD+ metabolism connects with calcium-dependent signalling.
This relationship demonstrates why CD38 cannot be viewed solely as an enzyme that reduces NAD+ availability.
Its enzymatic products can also participate in important cellular signalling pathways.
CD38 vs Sirtuins: What's the Difference?
CD38 and sirtuins both use NAD+, but their biological functions differ.
CD38 primarily acts as an NAD+-metabolising enzyme, producing molecules such as ADP-ribose and contributing to calcium-related signalling.
Sirtuins are NAD+-dependent enzymes involved in protein deacylation and the regulation of cellular processes.
Although both consume NAD+, they use it in different biochemical reactions.
Researchers are interested in how the activities of these enzymes interact through their dependence on NAD+ availability.
However, it would be inaccurate to suggest that CD38 and sirtuins always compete directly for a single, uniformly distributed NAD+ pool.
Their activities depend on enzyme localisation, substrate availability and cellular conditions.
For more information, explore our NAD+ and Sirtuins research guide.
CD38 vs PARP Enzymes
CD38 and poly(ADP-ribose) polymerases (PARPs) are both involved in NAD+ consumption.
However, their primary research applications differ.
CD38 is commonly investigated in relation to NAD+ turnover, immune-cell biology and calcium signalling.
PARP enzymes are studied extensively for their involvement in ADP-ribosylation, DNA damage responses and cellular stress signalling.
Both enzyme families use NAD+ as a substrate, making them relevant to investigations of cellular NAD+ availability.
Researchers may examine these pathways together when studying how cells coordinate metabolic regulation and responses to stress.
For further information, read our NAD+ and PARP Enzymes research guide.
CD38 and NAD+ Biosynthesis
NAD+ availability is influenced not only by consumption but also by biosynthesis and recycling.
Cells can produce NAD+ through several biochemical pathways, including pathways involving nicotinamide, nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR).
CD38 can also metabolise NMN under certain conditions, making its relationship with NAD+ precursors particularly interesting.
Researchers investigate how precursor availability, enzyme activity and cellular compartmentalisation interact to influence NAD+ homeostasis.
These relationships are important because increasing the availability of an NAD+ precursor does not necessarily produce the same metabolic response in every tissue or experimental system.
Our NAD+ vs NMN vs NR research guide explains the differences between these molecules and their roles in NAD+ metabolism.
Why Do Researchers Study NAD+ and CD38 Together?
The relationship between NAD+ and CD38 provides a useful model for investigating how cells regulate essential metabolic molecules.
Research commonly focuses on:
-
CD38 expression and enzymatic activity
-
NAD+ consumption and turnover
-
Immune-cell metabolism
-
Calcium-dependent signalling
-
NAD+ biosynthesis and recycling
-
Age-associated metabolic changes
-
Interactions between NAD+-consuming enzymes
These research areas contribute to a broader understanding of cellular metabolism and biochemical regulation.
Importantly, findings from cell cultures, animal models and isolated enzyme systems must be interpreted within their experimental context.
They do not establish clinical effectiveness or justify human use of research compounds.
Frequently Asked Questions
What does CD38 do to NAD+?
CD38 primarily acts as an NAD+ glycohydrolase, metabolising NAD+ into nicotinamide and ADP-ribose. It can also produce smaller amounts of cyclic ADP-ribose through additional enzymatic activity.
Is CD38 an NAD+-consuming enzyme?
Yes. CD38 is recognised as an important NAD+-consuming enzyme and is widely studied for its involvement in NAD+ metabolism and cellular signalling.
Does CD38 increase with age?
Some experimental studies have reported increased CD38 expression or activity in particular tissues during ageing. However, these changes vary by tissue, cell type and experimental model.
What is the relationship between CD38 and sirtuins?
Both use NAD+ as a substrate, but they perform different biochemical functions. Researchers investigate how NAD+ availability and cellular conditions influence their respective activities.
Is CD38 involved in inflammation?
CD38 is expressed by various immune cells, and its expression can be influenced by inflammatory signalling. Researchers investigate these relationships in immunology and metabolic research.
Is CD38 the same as PARP?
No. CD38 and PARP enzymes both consume NAD+, but their enzymatic reactions and biological functions differ.
Why is CD38 important in NAD+ research?
CD38 helps researchers investigate NAD+ consumption, cellular signalling and the regulation of NAD+ availability across different biological systems.
Conclusion
CD38 is an important component of NAD+ metabolism and cellular signalling.
Through its NADase activity, CD38 contributes to NAD+ consumption while also participating in biochemical pathways associated with calcium regulation and immune-cell function.
Research into CD38 has expanded understanding of how NAD+ availability is regulated and why NAD+ metabolism can differ between tissues, cell types and experimental conditions.
Alongside sirtuins and PARP enzymes, CD38 forms part of a wider network of NAD+-dependent biochemical pathways.
Understanding these relationships provides valuable context for laboratory investigations into cellular metabolism and NAD+ regulation.
Explore NAD+ Research Compounds
Gaia Peptides supplies UK-manufactured NAD+ research preparations for controlled laboratory research applications.
Explore our NAD+ 1000mg Research Peptide Pen for further product specifications and research documentation.
Research Use Only: Gaia Peptides products are supplied exclusively for laboratory research purposes. They are not intended for human or animal administration, clinical treatment or diagnostic use.
Scientific references
The article draws on established research into CD38 and NAD+ metabolism, including: